Clinical Trial Update: Inturlekin L33 in Ankylosing Spondylities Patients and Its Relation to Subclinical Atherosclerosis

View source ↗

Summary

A clinical trial update notes a planned study of Inturlekin L33 in Ankylosing Spondylitis to evaluate its relation to subclinical atherosclerosis; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Inturlekin L33

Snippet

Sponsor: Assiut University | Conditions: Ankylosing Spondylitis | Status: NOT_YET_RECRUITING